Cargando…

Kinetic profiling and functional characterization of 8-phenylxanthine derivatives as A(2B) adenosine receptor antagonists

A(2B) adenosine receptor (A(2B)AR) antagonists have therapeutic potential in inflammation-related diseases such as asthma, chronic obstructive pulmonary disease and cancer. However, no drug is currently clinically approved, creating a demand for research on novel antagonists. Over the last decade, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vlachodimou, Anna, de Vries, Henk, Pasoli, Milena, Goudswaard, Miranda, Kim, Soon-Ai, Kim, Yong-Chul, Scortichini, Mirko, Marshall, Melissa, Linden, Joel, Heitman, Laura H., Jacobson, Kenneth A., IJzerman, Adriaan P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358681/ https://www.ncbi.nlm.nih.gov/pubmed/35395239 http://dx.doi.org/10.1016/j.bcp.2022.115027

Ejemplares similares

Label-free detection of transporter activity via GPCR signalling in living cells: A case for SLC29A1, the equilibrative nucleoside transporter 1
por: Vlachodimou, Anna, et al.
Publicado: (2019)

Scintillation proximity assay (SPA) as a new approach to determine a ligand’s kinetic profile. A case in point for the adenosine A(1) receptor
por: Xia, Lizi, et al.
Publicado: (2015)

Synthesis and Evaluation of Phenylxanthine Derivatives as Potential Dual A2AR Antagonists/MAO-B Inhibitors for Parkinson’s Disease
por: Wang, Xuebao, et al.
Publicado: (2017)

Molecular probes for the human adenosine receptors
por: Yang, Xue, et al.
Publicado: (2020)

A covalent antagonist for the human adenosine A(2A) receptor
por: Yang, Xue, et al.
Publicado: (2016)

Structure–Affinity Relationships and Structure–Kinetics Relationships of Pyrido[2,1-f]purine-2,4-dione Derivatives as Human Adenosine A(3) Receptor Antagonists
por: Xia, Lizi, et al.
Publicado: (2017)

A two‐state model for the kinetics of competitive radioligand binding
por: Guo, Dong, et al.
Publicado: (2018)

A live cell NanoBRET binding assay allows the study of ligand-binding kinetics to the adenosine A(3) receptor
por: Bouzo-Lorenzo, Monica, et al.
Publicado: (2019)

Structure–Affinity Relationships and Structure–Kinetic Relationships of 1,2-Diarylimidazol-4-carboxamide Derivatives as Human Cannabinoid 1 Receptor Antagonists
por: Xia, Lizi, et al.
Publicado: (2017)

Identification of V6.51L as a selectivity hotspot in stereoselective A(2B) adenosine receptor antagonist recognition
por: Wang, Xuesong, et al.
Publicado: (2021)

Putative role of the adenosine A(3) receptor in the antiproliferative action of N(6)-(2-isopentenyl)adenosine
por: Blad, Clara C., et al.
Publicado: (2011)

Cancer-Related Somatic Mutations in Transmembrane Helices Alter Adenosine A1 Receptor Pharmacology
por: Wang, Xuesong, et al.
Publicado: (2022)

International Union of Basic and Clinical Pharmacology. CXII: Adenosine Receptors: A Further Update
por: IJzerman, Adriaan P., et al.
Publicado: (2022)

Flexible modulation of agonist efficacy at the human A(3 )adenosine receptor by the imidazoquinoline allosteric enhancer LUF6000
por: Gao, Zhan-Guo, et al.
Publicado: (2008)

Internalization and desensitization of adenosine receptors
por: Klaasse, Elisabeth C., et al.
Publicado: (2007)

Deciphering conformational selectivity in the A(2A) adenosine G protein-coupled receptor by free energy simulations
por: Jespers, Willem, et al.
Publicado: (2021)

Acyl-Hydrazide Derivatives of a Xanthine Carboxylic Congener (XCC) as Selective Antagonists at Human A(2B) Adenosine Receptors
por: Kim, Yong-Chul, et al.
Publicado: (1999)

A(3) Adenosine Receptor Allosteric Modulator Induces an Anti-Inflammatory Effect: In Vivo Studies and Molecular Mechanism of Action
por: Cohen, Shira, et al.
Publicado: (2014)

An Affinity-Based Probe for the Human Adenosine A(2A) Receptor
por: Yang, Xue, et al.
Publicado: (2018)

Development of Covalent Ligands for G Protein-Coupled Receptors: A Case for the Human Adenosine A(3) Receptor
por: Yang, Xue, et al.
Publicado: (2019)

Structure of CC Chemokine Receptor 2 with Orthosteric and Allosteric Antagonists
por: Zheng, Yi, et al.
Publicado: (2016)

Structure-Activity Relationships of the Sustained Effects of Adenosine A2A Receptor Agonists Driven by Slow Dissociation Kinetics
por: Hothersall, J. Daniel, et al.
Publicado: (2017)

A Chemical Biological Approach to Study G Protein-Coupled Receptors: Labeling the Adenosine A(1) Receptor Using an Electrophilic Covalent Probe
por: Beerkens, Bert L. H., et al.
Publicado: (2022)

Allosteric modulation of adenosine receptors
por: Göblyös, Anikó, et al.
Publicado: (2008)

A novel CCR2 antagonist inhibits atherogenesis in apoE deficient mice by achieving high receptor occupancy
por: Bot, Ilze, et al.
Publicado: (2017)

Functional selectivity of adenosine receptor ligands
por: Verzijl, Dennis, et al.
Publicado: (2011)

Quantitative prediction of selectivity between the A(1) and A(2A) adenosine receptors
por: Burggraaff, Lindsey, et al.
Publicado: (2020)

Synthesis and Pharmacological Evaluation of Triazolopyrimidinone Derivatives as Noncompetitive, Intracellular Antagonists for CC Chemokine Receptors 2 and 5
por: Ortiz Zacarías, Natalia V., et al.
Publicado: (2019)

Pathophysiological Role and Medicinal Chemistry of A(2A) Adenosine Receptor Antagonists in Alzheimer’s Disease
por: Merighi, Stefania, et al.
Publicado: (2022)

Development of an Affinity-Based Probe to Profile Endogenous Human Adenosine A(3) Receptor Expression
por: Beerkens, Bert L. H., et al.
Publicado: (2023)

From receptor binding kinetics to signal transduction; a missing link in predicting in vivo drug-action
por: Nederpelt, Indira, et al.
Publicado: (2017)

Effect of Adenosine Receptor Antagonists on Adenosine-Pretreated PC12 Cells Exposed to Paraquat
por: Shang, Liangcheng, et al.
Publicado: (2022)

GPCR Agonist-to-Antagonist Conversion: Enabling the Design of Nucleoside Functional Switches for the A(2A) Adenosine Receptor
por: Shiriaeva, Anna, et al.
Publicado: (2022)

Crystal Structure and Subsequent Ligand Design of a Nonriboside Partial Agonist Bound to the Adenosine A(2A) Receptor
por: Amelia, Tasia, et al.
Publicado: (2021)

Limits of Ligand Selectivity from Docking to Models: In Silico Screening for A(1) Adenosine Receptor Antagonists
por: Kolb, Peter, et al.
Publicado: (2012)

Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
por: Tosh, Dilip K., et al.
Publicado: (2018)

Identification of Novel Adenosine A(2A) Receptor Antagonists by Virtual Screening
por: Langmead, Christopher J., et al.
Publicado: (2012)

Irreversible Antagonists for the Adenosine A(2B) Receptor †
por: Temirak, Ahmed, et al.
Publicado: (2022)

Adenosine-Related Mechanisms in Non-Adenosine Receptor Drugs
por: Jacobson, Kenneth A., et al.
Publicado: (2020)

Pharmacological characterisation of novel adenosine A(3) receptor antagonists
por: Barkan, Kerry, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_jjc0h83d75f4ho5ldvhbvhijln